73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study: AI outperforms standard risk model for predicting breast cancer

Study: AI outperforms standard risk model for predicting breast cancer

by Radiological Society of North AmericaRight medial lateral oblique (RMLO) screening mammograms show negative results from 2016 in (A) a 73-year-old woman with Mirai artificial intelligence (AI)

Study: AI outperforms standard risk model for predicting breast cancer

by Radiological Society of North AmericaRight medial lateral oblique (RMLO) screening mammograms show negative results from 2016 in (A) a 73-year-old woman with Mirai artificial intelligence (AI)
A new tumor-suppressive gene that boosts personalized treatment response in breast cancer

A new tumor-suppressive gene that boosts personalized treatment response in breast cancer

by The University of Hong KongGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111821A research team from LKS Faculty of Medicine, the University of Hong Kong

A new tumor-suppressive gene that boosts personalized treatment response in breast cancer

by The University of Hong KongGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111821A research team from LKS Faculty of Medicine, the University of Hong Kong
Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySomatic Point Mutations in TNAC and LK-TNBC. The top 16 significantly mutated genes as determined by the dNdScv algorithm (p &lt

Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySomatic Point Mutations in TNAC and LK-TNBC. The top 16 significantly mutated genes as determined by the dNdScv algorithm (p &lt
Existing cancer drugs have potential to benefit thousands more patients, research shows

Existing cancer drugs have potential to benefit thousands more patients, research shows

byInstitute of Cancer ResearchSF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response. Credit:Nature Genetics(2023). DOI: 1

Existing cancer drugs have potential to benefit thousands more patients, research shows

byInstitute of Cancer ResearchSF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response. Credit:Nature Genetics(2023). DOI: 1
Researchers discuss reassessing COVID-19 precautions in 2023

Researchers discuss reassessing COVID-19 precautions in 2023

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper titled "Reassessing the risks and benefits of COVID-19 precautions in 2023" has been published inOncotarget

Researchers discuss reassessing COVID-19 precautions in 2023

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper titled "Reassessing the risks and benefits of COVID-19 precautions in 2023" has been published inOncotarget
Continuity of care needed from the 'front of the pathway' to the back for cancer survivors, reports study

Continuity of care needed from the 'front of the pathway' to the back for cancer survivors, reports study

byUniversity of OtagoCredit: Pixabay/CC0 Public DomainAfter undergoing cancer treatment, many survivors deal with a range of psycho-social and physical issues but support for them is limited, ne

Continuity of care needed from the 'front of the pathway' to the back for cancer survivors, reports study

byUniversity of OtagoCredit: Pixabay/CC0 Public DomainAfter undergoing cancer treatment, many survivors deal with a range of psycho-social and physical issues but support for them is limited, ne
Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

October 2023Katie RobinsonPatients undergoing a human leukocyte antigen (HLA)-matched allogeneic hematopoietic cell transplantation (alloHCT) with reduced-intensity conditioning who received a prophyl

Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

October 2023Katie RobinsonPatients undergoing a human leukocyte antigen (HLA)-matched allogeneic hematopoietic cell transplantation (alloHCT) with reduced-intensity conditioning who received a prophyl
Specialized immune cells carry potential for new cancer immunotherapies

Specialized immune cells carry potential for new cancer immunotherapies

byLeiden UniversityTumor-infiltrating Vδ1 and Vδ3 T cell subsets display hallmarks of cytotoxic activity in MMR-d colon cancers. a, UMAP embedding showing the clustering of γδ T cells (n = 4,442

Specialized immune cells carry potential for new cancer immunotherapies

byLeiden UniversityTumor-infiltrating Vδ1 and Vδ3 T cell subsets display hallmarks of cytotoxic activity in MMR-d colon cancers. a, UMAP embedding showing the clustering of γδ T cells (n = 4,442
Researchers key to advance care planning with cancer clinical trial patients

Researchers key to advance care planning with cancer clinical trial patients

by University of Pennsylvania School of NursingConnie M. Ulrich, PhD, RN, FAAN, the Lillian S. Brunner Chair in Medical and Surgical Nursing at the University of Pennsylvania School of Nursing (P

Researchers key to advance care planning with cancer clinical trial patients

by University of Pennsylvania School of NursingConnie M. Ulrich, PhD, RN, FAAN, the Lillian S. Brunner Chair in Medical and Surgical Nursing at the University of Pennsylvania School of Nursing (P
Microbial signature of colorectal cancer-associated mutations identified

Microbial signature of colorectal cancer-associated mutations identified

by American Society for MicrobiologyCredit: CC0 Public DomainFor about 40% of people diagnosed with colorectal cancer (CRC), the tumor carries a mutation in a gene called KRAS. Many of those muta

Microbial signature of colorectal cancer-associated mutations identified

by American Society for MicrobiologyCredit: CC0 Public DomainFor about 40% of people diagnosed with colorectal cancer (CRC), the tumor carries a mutation in a gene called KRAS. Many of those muta
Diet may influence the spread of a deadly type of breast cancer, study finds

Diet may influence the spread of a deadly type of breast cancer, study finds

by Cedars-Sinai Medical CenterThree-dimensional cell culture of breast cancer cells. Credit: National Institutes of Health (Dao Tiensinh)A single protein building block commonly found in food may hold

Diet may influence the spread of a deadly type of breast cancer, study finds

by Cedars-Sinai Medical CenterThree-dimensional cell culture of breast cancer cells. Credit: National Institutes of Health (Dao Tiensinh)A single protein building block commonly found in food may hold
New details revealed to explain how tumors recruit blood vessels

New details revealed to explain how tumors recruit blood vessels

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainA study by University of North Carolina Lineberger Comprehensive Cancer Center researchers helps explain

New details revealed to explain how tumors recruit blood vessels

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainA study by University of North Carolina Lineberger Comprehensive Cancer Center researchers helps explain